The influence of pretransplant interferon-α therapy on survival after allogenous BMT in patients with CML.

被引：0
|
作者：
Hochhaus, A [1 ]
Kolb, HJ [1 ]
Hasford, J [1 ]
Berger, U [1 ]
Muth, A [1 ]
Pfirrmann, M [1 ]
Hehlmann, R [1 ]
机构：
[1] Univ Heidelberg, Klinikum Mannheim, Med Klin, Mannheim, Germany
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
191
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [21] Histologic changes of the liver of patients with chronic hepatitis B after interferon-α therapy
    Mach, T
    Janas-Skulina, U
    Librant-Suska, M
    Szczepanski, W
    Warunek, W
    Ciesla, A
    Zejc-Bajsarowicz, M
    Sobczyk-Krupiarz, I
    JOURNAL OF HEPATOLOGY, 2001, 34 : 203 - 203
  • [22] Pretransplant ribavirin and interferon-α therapy for rhinovirus interstitial pneumonia in a RAG1-deficient infant
    Harada, Nobutaka
    Sonoda, Motoshi
    Ishimura, Masataka
    Eguchi, Katsuhide
    Kinoshita, Keishiro
    Matsuoka, Wakato
    Motomura, Yoshitomo
    Kaku, Noriyuki
    Kawaguchi, Naoki
    Takeuchi, Takami
    Ohga, Shouichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 362 - 365
  • [23] Interferon-α therapy – which patients will develop depression?
    Reactions Weekly, 1999, 750 (1) : 4 - 4
  • [24] Interferon-α as maintenance therapy in patients with multiple myeloma
    Schaar, CG
    Kluin-Nelemans, HC
    te Marvelde, C
    le Cessie, S
    Breed, WP
    Fibbe, WE
    van Deijk, WA
    Fickers, MM
    Roozendaal, KJ
    Wijermans, PW
    ANNALS OF ONCOLOGY, 2005, 16 (04) : 634 - 639
  • [25] Recombinant interferon-α therapy in patients with follicular lymphoma
    Ozer, H
    Wiernik, PH
    Giles, F
    Tendler, C
    CANCER, 1998, 82 (10) : 1821 - 1830
  • [26] Acquired factor VIII inhibitor in a patient with CML receiving chronic interferon-α therapy.
    English, KE
    Brien, WF
    Howson-Jan, K
    Kovacs, MJ
    BLOOD, 1999, 94 (10) : 273B - 273B
  • [27] ATG as part of the pretransplant conditioning regimen reduces transplant-related mortality in CML patients undergoing allogeneic BMT
    Stockschlader, M
    Kruger, W
    Betker, R
    Loliger, C
    deWit, M
    Horstmann, M
    Kroger, N
    Erttmann, R
    Zander, R
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 679 - 679
  • [28] Transcriptional responses in HCV before and after interferon-α therapy
    George, MM
    Certa, U
    Langen, H
    Srinivas, D
    Fairchild, RB
    Fairchild, AH
    van Thiel, DH
    HEPATOLOGY, 2004, 40 (04) : 344A - 344A
  • [29] Impact of interferon-αtherapy duration and chronic myelogenous leukemia (CML) history on Glivec ® (STI 571) response in interferon-resistant or intolerant CML patients in chronic and in accelerated phase.
    Michallet, M
    Le, QH
    Mates, M
    Berthaud, P
    Troncy, J
    Fiere, D
    Nicolini, F
    BLOOD, 2001, 98 (11) : 263B - 263B
  • [30] Pericarditis After Therapy with Interferon-α for Chronic Hepatitis C
    A. Boonen
    R. W. Stockbrügger
    Sj. van der Linden
    Clinical Rheumatology, 1999, 18 : 177 - 179
12345